{"id":"NCT04248868","sponsor":"Thrombolex, Inc.","briefTitle":"tPA by Endovascular Administration for the Treatment of Submassive PE Using CDT for the Reduction of Thrombus Burden","officialTitle":"Recombinant tPA by Endovascular Administration for the Treatment of Submassive Pulmonary Embolism Using Pharmaco-mechanical Catheter Directed Thrombolysis for the redUction of Thrombus burdEn","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-06-23","primaryCompletion":"2022-06-22","completion":"2022-06-23","firstPosted":"2020-01-30","resultsPosted":"2023-04-20","lastUpdate":"2023-04-20"},"enrollment":109,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Embolism"],"interventions":[{"type":"DEVICE","name":"The Bashir™ Endovascular Catheter","otherNames":[]},{"type":"DRUG","name":"r-tPA","otherNames":[]}],"arms":[{"label":"BEC Treatment","type":"EXPERIMENTAL"}],"summary":"To demonstrate the efficacy and safety of the Bashir™ Endovascular Catheter for the administration of pharmaco-mechanical catheter directed therapy using low dose r-tPA for the treatment of acute submassive pulmonary embolism.","primaryOutcome":{"measure":"Efficacy: RV/LV Ratio Difference","timeFrame":"48 hours after the completion of r-tPA treatment","effectByArm":[{"arm":"BEC Treatment","deltaMin":1.66,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":19,"countries":["United States"]},"refs":{"pmids":["36121244"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":109},"commonTop":["Arrhythmia","Apnoeic attack","Device operational issue","Insomnia","Electrolyte imbalance"]}}